Discovery on Target 2026 has ended. This guide stays up as the record of who was there. Next: Discovery on Target 2027, Oct 18–21, 2027 in Boston

Revolution Medicines at Discovery on Target 2026

Sep 28 – Oct 1, 2026 Boston, MA ~1.1k attendees Website

Revolution Medicines brings 4 presentations to Discovery on Target 2026 in Boston. Its program centres on RAS(ON) inhibitors, including an oral covalent tri-complex inhibitor selective for G12D. It also covers remodeling a cellular chaperone to reach diverse inhibitor profiles and shares views on start-up funding and partnerships.

OrganizationDiscovery on Target 2026 Attendance
Revolution Medicines
Redwood City, CA
Biotech
Oncology company developing oral RAS(ON) inhibitors for RAS-driven cancers.
Talk
Tue Sep 29
9:05am–9:35am
Zoldonrasib, an Oral, RAS(ON) G12D-Selective, Covalent, Tri-Complex Inhibitor
Lead Generation Strategies
Talk
Tue Sep 29
9:35am–10:05am
Panel
Wed Sep 30
5:50pm–6:30pm
Connect the DOTS for Start-Ups & Funding
Plenary · with Nova Rain Capital, Ilerabio
Panel
Thu Oct 1
7:30am–8:15am
Setting Up Collaborations & Partnerships
Plenary · with Johnson & Johnson

Explore the full Discovery on Target 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full Discovery on Target 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Revolution Medicines

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Discovery on Target or its organizers. Submit a correction